Reverse takeover transaction with NCAC (Tables)

10 Months Ended

Jan. 31, 2024

Reverse takeover transaction with NCAC

Summary of calculation of listing expenses

	Listing
	Expense
Consideration paid:
Shares issued to NCAC shareholders		7,794,659
Shares issued to settle NCAC liabilities		150,000
Shares issued to compensate advisors		446,000
Total consideration shares issued NCAC shareholders		8,390,659
Fair value of the common shares	$	3.55
Deemed consideration amount for the common shares issued	$	29,786,839
Net identifiable liability acquired:
Cash and cash equivalent	$	203
Accounts payable and accrued liabilities	$	(165)
NCAC promissory note (Note 10)	$	(1,615,501)
Derivative warrant liabilities (Note 9)	$	(595,358)
Net liabilities acquired	$	(2,210,821)
Listing Expense	$	31,997,660